Quantitative modelling predicts the impact of DNA methylation on RNA polymerase II traffic
暂无分享,去创建一个
B. Waclaw | A. Bird | B. Ramsahoye | P. Greulich | Miao Yu | Shaun Webb | Kashyap Chhatbar | Justyna Cholewa-Waclaw | Ruth Shah | O. Pusch | B. Wacław
[1] Leander M. Sinanan,et al. Structural Basis of MeCP2 Distribution on Non-CpG Methylated and Hydroxymethylated DNA. , 2017, Journal of molecular biology.
[2] A. Bird,et al. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain , 2017, PLoS genetics.
[3] C. Dean,et al. Slow Chromatin Dynamics Allow Polycomb Target Genes to Filter Fluctuations in Transcription Factor Activity , 2017, Cell systems.
[4] A. Bird,et al. Structure of the MeCP2–TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders , 2017, Proceedings of the National Academy of Sciences.
[5] I. Dodd,et al. Directing traffic on DNA—How transcription factors relieve or induce transcriptional interference , 2017, Transcription.
[6] Harrison W. Gabel,et al. DNA methylation in the gene body influences MeCP2-mediated gene repression , 2016, Proceedings of the National Academy of Sciences.
[7] A. Bird,et al. Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders , 2016, Wellcome open research.
[8] Harrison W. Gabel,et al. Disruption of DNA methylation-dependent long gene repression in Rett syndrome , 2015, Nature.
[9] John T. Lis,et al. Getting up to speed with transcription elongation by RNA polymerase II , 2015, Nature Reviews Molecular Cell Biology.
[10] Howard Y. Chang,et al. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.
[11] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[12] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[13] A. Bird,et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor , 2013, Nature Neuroscience.
[14] S. Henikoff,et al. Regulation of nucleosome dynamics by histone modifications , 2013, Nature Structural &Molecular Biology.
[15] Charles Y. Lin,et al. Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.
[16] G. Hon,et al. Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome , 2012, Cell.
[17] Sündüz Keles,et al. Normalization of ChIP-seq data with control , 2012, BMC Bioinformatics.
[18] Tanja Waldmann,et al. Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.
[19] Felix Krueger,et al. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..
[20] Feng Lin,et al. A signal-noise model for significance analysis of ChIP-seq with negative control , 2010, Bioinform..
[21] S. Peters,et al. The MECP2 duplication syndrome , 2010, American journal of medical genetics. Part A.
[22] Robert S. Illingworth,et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. , 2010, Molecular cell.
[23] Julien F. Ollivier,et al. Colored extrinsic fluctuations and stochastic gene expression , 2008, Molecular systems biology.
[24] R. Ghosh,et al. MeCP2-Chromatin Interactions Include the Formation of Chromatosome-like Structures and Are Altered in Mutations Causing Rett Syndrome* , 2007, Journal of Biological Chemistry.
[25] R. A. Blythe,et al. Nonequilibrium steady states of matrix-product form: a solver's guide , 2007, 0706.1678.
[26] A. Bird,et al. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.
[27] A. Harel-Bellan,et al. The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. , 2006, Genes & development.
[28] A. Bird,et al. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. , 2005, Molecular cell.
[29] M. Nakao,et al. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain , 2003, Journal of medical genetics.
[30] A. Bird,et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.
[31] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[32] A. Bird,et al. Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.
[33] B. Derrida. AN EXACTLY SOLUBLE NON-EQUILIBRIUM SYSTEM : THE ASYMMETRIC SIMPLE EXCLUSION PROCESS , 1998 .
[34] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[35] A. Bird,et al. MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.
[36] A. Bird,et al. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. , 1993, Nucleic acids research.
[37] A. Bird,et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.